Smith & Nephew plc (NYSE:SNN) Receives Consensus Rating of “Moderate Buy” from Brokerages

Smith & Nephew plc (NYSE:SNN) has earned an average rating of “Moderate Buy” from the six analysts that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company.

Several research firms recently weighed in on SNN. StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Monday, August 5th. UBS Group raised shares of Smith & Nephew from a “neutral” rating to a “buy” rating in a research report on Wednesday, June 5th. Finally, Deutsche Bank Aktiengesellschaft began coverage on shares of Smith & Nephew in a research report on Wednesday, July 24th. They issued a “buy” rating for the company.

Smith & Nephew Stock Down 0.3 %

SNN stock opened at $30.85 on Monday. Smith & Nephew has a 52-week low of $21.52 and a 52-week high of $31.24. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. The company’s 50-day simple moving average is $28.55 and its 200-day simple moving average is $26.72.

Institutional Investors Weigh In On Smith & Nephew

Several hedge funds and other institutional investors have recently bought and sold shares of SNN. CWM LLC increased its stake in Smith & Nephew by 68.6% in the fourth quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 388 shares during the period. Spire Wealth Management increased its stake in Smith & Nephew by 224.3% in the fourth quarter. Spire Wealth Management now owns 1,015 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 702 shares during the period. EverSource Wealth Advisors LLC increased its stake in Smith & Nephew by 75.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,227 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 526 shares during the period. Parallel Advisors LLC increased its stake in Smith & Nephew by 150.9% in the fourth quarter. Parallel Advisors LLC now owns 1,533 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 922 shares during the period. Finally, Mather Group LLC. increased its stake in Smith & Nephew by 9,735.3% in the second quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 1,655 shares during the period. 25.64% of the stock is currently owned by institutional investors and hedge funds.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.